Prospective registry trial of trans-arterial embolization for dural arteriovenous fistula using PHI
Not Applicable
Recruiting
- Conditions
- dural arteriovenous fistula
- Registration Number
- JPRN-UMIN000038325
- Lead Sponsor
- Kobe City Medical Center General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
Not provided
Exclusion Criteria
1. impossible to use heparin 2. history of severe alergic reaction to contrast media 3. impossible to navigate microcatheter to idea l position 4. intolelance to provocative test 5. no distal flow by vasospasm 6. liver dysfunction (AST 120U or larger) or re nal dysfunction (CRTN 2.0mg/dL or larger) 7. history of embolization using non-adhesive li quid material for target brain AVM 8. candidate to another approving trial 9. pregnant or possible to pregnancy lady 10. inappropriate patient for this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method curative occlusion at 180 days after embolization and no pprocedure related mortality, stroke and severe hemorrhagic event within 30days after surgical resection
- Secondary Outcome Measures
Name Time Method 1. recanalization at 180 days after embolization 2. re-treatment related to recanalization at 180 days after embolization 3. neurological symptoms related to recanalization at 180 days after embolization 4. any death at 180 days after embolization 5. any stroke at 180 days after embolization 6, neurological deterioration at 180 days after embolization 7. modified Rankin Scale at 180 days after embolization